Phase 1b Influenza Vaccine Study in Healthy Subjects
NCT01181336
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Influenza vaccine (FLU-v)
BIOLOGICAL:
FLU-v Control
Sponsor
PepTcell Limited